Advagene Biopharma Co. Ltd.

This study tested a new nasal spray called AD17002 to see if it is safe and can help control symptoms in adults allergic to house dust mites. Forty-eight participants with dust mite allergy received either the spray or a placebo (inactive substance) over three weeks. Researchers …

This study tested a new nasal spray called AD17002 for adults with moderate-to-severe eosinophilic asthma that is not well controlled by standard medications. The main goals were to see if the spray could improve lung function and asthma symptoms, and to check if it was safe for …